Related Experiment Video
Updated: Mar 21, 2026

07:41
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
10.4K
The physiological relevance of functional selectivity in dopamine signalling
International Journal of Obesity Supplements
|May 7, 2016
Summary
Dopamine (DA) signaling pathways show functional selectivity in behaviors. Beta-arrestin pathways influence locomotor activity but not conditioned place preference (CPP) for drugs like morphine and amphetamine.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Dopamine (DA) signaling is crucial for various behaviors.
- DA receptors can signal through G protein or β-arrestin pathways.
- Functional selectivity suggests these pathways mediate distinct behavioral outcomes.
Purpose of the Study:
- To investigate the role of G protein and β-arrestin signaling pathways in DA-dependent behaviors.
- To determine if dopamine receptor signaling exhibits functional selectivity.
- To examine the impact of β-arrestin deficiency and GSK3β deficiency on locomotor activity and conditioned place preference (CPP).
Main Methods:
- Utilized global β-arrestin knockout mice and D2 receptor-specific GSK3β knockout mice.
- Administered drugs like morphine and amphetamine to wild-type and knockout mice.
- Assessed locomotor activity and CPP as measures of DA-dependent behaviors.
Main Results:
- Mice lacking β-arrestin2 showed reduced locomotor responses to morphine and amphetamine.
- Mice deficient in GSK3β in D2R-expressing neurons had reduced locomotor response to amphetamine but not morphine.
- All tested mice exhibited normal CPP responses to both drugs, irrespective of genetic modifications.
Conclusions:
- β-arrestin-mediated dopamine receptor signaling is critical for locomotor responses to morphine and amphetamine.
- G protein-dependent signaling likely mediates the CPP response to these drugs.
- Dopamine-dependent behaviors demonstrate functional selectivity, with distinct pathways governing different responses.
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
10.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.5K
Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Spare Receptors
4.8K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
4.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Neurochemical Transmission: Sites of Drug Action
3.9K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.9K

